Joined Today: 0

OSCI Oscient Pharmaceuticals, Stock Message Board

All Messages

OSCI Message Board Home | Join The OSCI Group |

#60: Oscient Pharmaceuticals to Participate in the BMO Capital Markets Focus on Healthcare Conference
TheMachine	August 4, 2008 07:49:55 AM
Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the BMO Capital Markets Focus on Healthcare Conference on Tuesday, August 5, 2008 in New York... view message ignore post recommend post

#59: Oscient Pharmaceuticals to Participate in the Roth Capital Partners 20th Annual OC Growth Conference
NewsBot	April 7, 2008 09:43:18 PM
Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Roth Capital Partners 20th Annual OC Growth Conference on Thursday, February 21, 2008 in Dana Point,... view message ignore post recommend post

#58: Post Conference and Q3 Focus on CytRx Corporation, Oscient Pharmaceuticals Corporation, and Santarus, Inc.
FastFun	October 20, 2007 10:32:20 PM
Awareness Brings Added ValueComments made in this release are those of Maybach Financial Group and any questions or comments should be directed to the contact information located at the... view message ignore post recommend post

#57: Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Third Quarter Financial Results
FastFun	October 20, 2007 10:31:43 PM
Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial results for the third quarter ended September 30, 2007 on Wednesday, October 31, 2007 prior to the opening of the... view message ignore post recommend post

#56: Oscient Pharmaceuticals Provides Preliminary Revenue Results for the Third Quarter of 2007
FastFun	October 20, 2007 10:30:37 PM
Revenues increase approximately 25 percent from third quarter of 2006; Nine month revenues increase approximately 96 percent from prior year reflecting ANTARA® acquisition Oscient... view message ignore post recommend post

#55: Oscient Pharmaceuticals to Participate in the Natixis Bleichroeder Hidden Gems Conference
FastFun	October 20, 2007 10:29:40 PM
Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Natixis Bleichroeder Hidden Gems Conference on Monday, October 8, 2007 in New York City. The Company’s President... view message ignore post recommend post

#54: OSCI News Oscient Pharmaceuticals Commences Exchange Offers
NewsBot	March 29, 2007 04:33:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today announced that it has commenced offers to exchange up to $185,600,000 aggregate principal... view message ignore post recommend post

#53: OSCI News Oscient Pharmaceuticals Files Registration Statements for Proposed Exchange Offers with Holders of its Convertible Notes and an Offering of up to $30,000,000 Principal Amount of New 3.50% Convertible Senior Notes due 2011
NewsBot	March 15, 2007 04:17:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today announced that it has filed registration statements with the Securities and Exchange Commission... view message ignore post recommend post

#52: OSCI News CORRECTED: Webcast Alert: Oscient Pharmaceuticals to Present at Cowen & Company 27th Annual Healthcare Conference
NewsBot	March 8, 2007 10:57:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Cowen & Company 27th Annual Healthcare Conference on Thursday, March 15,... view message ignore post recommend post

#51: OSCI News Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
NewsBot	March 2, 2007 05:30:00 AM
MONTREAL and WALTHAM, Mass.--(BUSINESS WIRE)--Abbott Canada, the Canadian affiliate of Abbott, has launched Oscient Pharmaceuticals Corporation’s (Nasdaq: OSCI) fluoroquinolone... view message ignore post recommend post

#50: OSCI News Oscient Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2006
NewsBot	February 27, 2007 04:30:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today reported financial results for the fourth quarter and fiscal year ended December 31, 2006. The... view message ignore post recommend post

#49: OSCI News New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
NewsBot	February 22, 2007 05:30:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation’s (Nasdaq: OSCI) fluoroquinolone antibiotic, FACTIVE® (gemifloxacin mesylate) tablets, is recommended,... view message ignore post recommend post

#48: OSCI News Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
NewsBot	February 15, 2007 08:38:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial results for the fourth quarter and fiscal year ended December 31, 2006 on... view message ignore post recommend post

#47: OSCI News Oscient Pharmaceuticals Provides Preliminary Revenue Results for Fourth Quarter and Fiscal Year 2006
NewsBot	January 8, 2007 06:24:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today announced preliminary revenue results for the fourth quarter and fiscal year ended December... view message ignore post recommend post

#46: OSCI News Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
NewsBot	January 4, 2007 05:30:00 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has granted the commercialization rights to FACTIVE(R) (gemifloxacin mesylate) tablets in Europe to... view message ignore post recommend post

Group Home | Login if you want to post a message